Covaxin Gets WHO's Approval

Bharat Biotech's Covaxin has been granted Emergency Use Listing approval by the World Health Organisation (WHO).

The global health group's Technical Advisory Group (TAG) issued the final decision.

COVID-19 Vaccine: Myths and Facts
Debunking several misconceptions or myths that have surfaced regarding covid vaccination is important and focus on the facts related to COVID-19 vaccines.

‘WHO has granted emergency use listing (EUL) to Covaxin, developed by Bharat Biotech, adding to a growing portfolio of vaccines validated by WHO for the prevention of Covid-19.’

The source said that Prime Minister Narendra Modi had pushed for Covaxin approval at G20 meet with WHO Director General Dr Tedros Adhanom Ghebreyesus.

The emergency listing got delayed as the TAG sought some additional information from vaccines manufacturers for final risk assessment.

The TAG last met on October 27 and had agreed upon to conduct the final risk assessment after receiving additional data from the manufacturer. Bharat Biotech was expected to submit the additional data by this weekend.

India can Supply 5 Billion Covaxin Dosages to World
India continued to be a trusted partner in the context of reliable supply chains, the IT sector, the BPOs, despite the challenges faced during the pandemic.

Covaxin, which was co-developed by Hyderabad-based Bharat Biotech, in collaboration with the government's Indian Council of Medical Research (ICMR), was granted emergency authorisation in the country in January.

It has demonstrated 77.8 per cent effectiveness against symptomatic Covid-19 and 65.2 per cent protection against the new Delta variant. Bharat Biotech said that it concluded the final analysis of Covaxin efficacy from Phase 3 trials.

WHO Seeks More Clarification on Emergency Use of Covaxin
Technical Advisory Group for Emergency Use Listing (TAG-EUL) provides recommendations to the World Health Organization (WHO) on whether a Covid-19 vaccine can be listed for emergency use or not.

The global health body has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson 7 Johnson - Janssen, Moderna, and Sinopharm for emergency use against Covid-19.

Source-IANS

ICMR Says Covaxin Single-dose to Covid Infected Equivalent to 2 Doses for Unaffected
In COVID-infected individuals a single dose Covaxin provides similar immune response as those without COVID-19 infection history with two doses of vaccine.